Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Introduction</h3><p>Prostate cancer has significant mortality and metastasis rate in the male. Unfortunately, effective treatment for patients with advanced prostate cancer is still lacking. Verbascoside, a phenylethanoid glycoside, displays various pharmacological properties, such as the anti‐cancer activities. The present study aimed to evaluate the effects of purified verbascoside on human prostate cancer and the associated molecular mechanisms.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Materials and Methods</h3><p>The human prostate cancer cell lines, Du‐145 and PC‐3, were treated with various concentrations of verbascoside (0.1, 1, 10 μM) for 24 h followed by the examination of cell viability using MTT and trypan blue exclusion assays. Cell migration and invasion capacities were assessed by wound healing assay and transwell system. Western blot and immunofluorescence staining were used to detect the expression of epithelial‐mesenchymal transition (EMT)‐associated factors, components of transforming growth factor (TGF‐β)/Smad signaling, and high‐mobility group box (HMGB)/receptor for advanced glycation end‐products (RAGE) axis.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>Verbascoside treatment significantly inhibited cell proliferation, migration, and invasion abilities of Du‐145 and PC‐3 cells. We showed that verbascoside decreased the expression of EMT promotors, Snail and Slug, and increased the expression of E‐cadherin. Moreover, the expression level of alpha‐smooth muscle actin was downregulated by verbascoside as well. Besides, we found that the TGF‐β pathway was suppressed, which was demonstrated by the diminished expression of type I and II TGF‐β receptors and phosphorylated Smad2/3 along with the upregulated Smad7. Our data suggested that this downregulation of TGF‐β signaling was mediated by repression of HMGB 1 (HMGB1)/RAGE axis.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusion</h3><p>Verbascoside mitigated the cell proliferation and aggressiveness of prostate cancer via downregulation of TGF‐β‐associated EMT progression through HMGB1/RAGE suppression. Collectively, our findings revealed that verbascoside may be a beneficial dietary supplement for prostate cancer patients.</p></section>

Arenobufagin Inhibits Prostate Cancer Epithelial-Mesenchymal Transition and Metastasis by Down-Regulating Β-Catenin.

Metformin Inhibits Prostate Cancer Progression by Targeting Tumor-Associated Inflammatory Infiltration

Arenobufagin inhibits lung metastasis of colorectal cancer by targeting c-MYC/Nrf2 axis

Ursolic Acid Inhibits Epithelial-Mesenchymal Transition through the Axl/NF- κ B Pathway in Gastric Cancer Cells.

Apigenin inhibits migration and invasion via modulation of epithelial mesenchymal transition in prostate cancer.

Tag performance evaluation and optimisation of Gen 2 reader communication for radio frequency identification deployment in supply chains

Baicalein Inhibits The Invasion, Migration And Epithelial-Mesenchymal Transition Of Bgc-823 Cells Through Nf-Kappa B/Snail Signaling Pathway

Bufalin Inhibits Tgf-Beta-Induced Epithelial-To-Mesenchymal Transition And Migration In Human Lung Cancer A549 Cells By Downregulating Tgf-Beta Receptors

Echinatin Inhibits Tumor Growth and Synergizes with Chemotherapeutic Agents Against Human Bladder Cancer Cells by Activating P38 and Suppressing Wnt/β-catenin Pathways

Curcumin inhibits prostate cancer by upregulating miR‐483‐3p and inhibiting UBE2C

[The usefulness of platelet function evaluation in clinical practice].

Verbascoside inhibits the epithelial‐mesenchymal transition of prostate cancer cells through high‐mobility group box 1/receptor for advanced glycation end‐products/ TGF ‐β pathway

Bufalin targeting BFAR inhibits the occurrence and metastasis of gastric cancer through PI3K/AKT/mTOR signal pathway

Bufalin Suppresses Hepatocellular Carcinoma Invasion and Metastasis by Targeting HIF-1α Via the PI3K/AKT/mTOR Pathway.

Arenobufagin, isolated from Bufo viridis toad venom, inhibits A549 cells proliferation by inducing apoptosis and G2/M cell cycle arrest

Curcumin blunts epithelial-mesenchymal transition to alleviate invasion and metastasis of prostate cancer through the JARID1D demethylation

Neuron‐glial cell communication in the traumatic stress‐induced immunomodulation

Cucurbitacin B inhibits TGF-β1-induced epithelial–mesenchymal transition (EMT) in NSCLC through regulating ROS and PI3K/Akt/mTOR pathways

Epicatechin gallate prevents the de novo synthesis of fatty acid and the migration of prostate cancer cells

Antrodin C Inhibits Epithelial-to-Mesenchymal Transition and Metastasis of Breast Cancer Cells via Suppression of Smad2/3 and β-Catenin Signaling Pathways

Curcumin Suppresses Epithelial-to-mesenchymal Transition and Metastasis of Pancreatic Cancer Cells by Inhibiting Cancer-Associated Fibroblasts.